Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Liminatus Pharma Inc’s stock clocked out at $0.71, down -4.07% from its previous closing price of $0.74. In other words, the price has decreased by -$4.07 from its previous closing price. On the day, 0.14 million shares were traded. LIMN stock price reached its highest trading level at $0.7275 during the session, while it also had its lowest trading level at $0.68.
Ratios:
To gain a deeper understanding of LIMN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.42 and its Current Ratio is at 0.42.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 19161760 and an Enterprise Value of 19879758.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.38, which has changed by -0.90820897 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -32.52%, while the 200-Day Moving Average is calculated to be -87.84%.
Shares Statistics:
It appears that LIMN traded 415.29K shares on average per day over the past three months and 84020 shares per day over the past ten days. A total of 27.06M shares are outstanding, with a floating share count of 5.56M. Insiders hold about 79.47% of the company’s shares, while institutions hold 0.97% stake in the company. Shares short for LIMN as of 1764288000 were 266377 with a Short Ratio of 0.29, compared to 1761868800 on 378072.
